Shopping Cart
Remove All
Your shopping cart is currently empty
Cevostamab (Synonyms: RO7187797, RO 7187797, RG6160, RG 6160, BFCR4350A, BFCR 4350A)
Catalog No. T76998 Copy Product Info
🥰Excellent
Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized bispecific antibody targeting FcRH5/CD3. It binds to FcRH5 expressed on multiple myeloma (MM) cells and CD3 on T cells, promoting T cell synapse formation and inhibiting B-cell malignancies.
Cevostamab
Copy Product Info🥰Excellent
Catalog No. T76998
Synonyms RO7187797, RO 7187797, RG6160, RG 6160, BFCR4350A, BFCR 4350A
Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized bispecific antibody targeting FcRH5/CD3. It binds to FcRH5 expressed on multiple myeloma (MM) cells and CD3 on T cells, promoting T cell synapse formation and inhibiting B-cell malignancies.
Cevostamab
Cas No. 2249888-53-5
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $290 | - | In Stock | |
| 5 mg | $755 | - | In Stock | |
| 10 mg | $1,200 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:95.1% (SDS-PAGE); 99.6% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized bispecific antibody targeting FcRH5/CD3. It binds to FcRH5 expressed on multiple myeloma (MM) cells and CD3 on T cells, promoting T cell synapse formation and inhibiting B-cell malignancies. |
| In vitro | Cevostamab exhibits potent, dose-dependent killing effects on B cells and bone marrow plasma cells in peripheral blood mononuclear cell (PBMC)/bone marrow monocyte cell (BMMC) samples from rhesus monkeys [1]. |
| In vivo | Cevostamab (0.5 mg/kg; intravenous; weekly) inhibited growth of MOLP-2 tumors in mice reconstituted with human immune cells. |
| Synonyms | RO7187797, RO 7187797, RG6160, RG 6160, BFCR4350A, BFCR 4350A |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal, Bispecific |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CD3 & FCRL5/CD307e/FcRH5 |
| Molecular Weight | 146.20 kDa |
| Cas No. | 2249888-53-5 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Cevostamab | purchase Cevostamab | Cevostamab cost | order Cevostamab | Cevostamab in vivo | Cevostamab in vitro | Cevostamab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.